Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001564590-21-006795
Filing Date
2021-02-19
Accepted
2021-02-19 08:34:02
Documents
8
Period of Report
2021-02-19

Document Format Files

Seq Description Document Type Size
1 6-K bntx-6k_20210219.htm 6-K 17698
2 EX-99.1 bntx-ex991_6.htm EX-99.1 52946
3 GRAPHIC gl14jxwzgl5n000001.jpg GRAPHIC 14741
4 GRAPHIC gqir0lscxvqj000001.jpg GRAPHIC 780
5 GRAPHIC gqir0lscxvqj000003.jpg GRAPHIC 780
6 GRAPHIC gqir0lscxvqj000002.jpg GRAPHIC 780
7 GRAPHIC gl14jxwzgl5n000002.jpg GRAPHIC 9298
8 GRAPHIC gqir0lscxvqj000004.jpg GRAPHIC 780
  Complete submission text file 0001564590-21-006795.txt   109954
Mailing Address AN DER GOLDGRUBE 12 MAINZ 2M 55131
Business Address AN DER GOLDGRUBE 12 MAINZ 2M 55131 0049613190847081
BioNTech SE (Filer) CIK: 0001776985 (see all company filings)

EIN.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39081 | Film No.: 21652117
SIC: 2836 Biological Products, (No Diagnostic Substances)